The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
Looking for a particular NeuroPace employee's phone or email?
The NeuroPace annual revenue was $45.3 million in 2026.
Frank Fischer is the Chairman Of The Board of NeuroPace.
224 people are employed at NeuroPace.
NeuroPace is based in Mountain View, California.
The NAICS codes for NeuroPace are [334, 339, 33].
The SIC codes for NeuroPace are [38, 384, 382].